AAAAAA

   
Results: 1-3 |
Results: 3
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 Part III: Pharmacokinetics, metabolism, dose dependancy and gender effect after single or repeated administration to human healthy volunteers
Authors: Duchene, P Laneury, JP Tran, G Ladure, P Ollivier, P Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 Part III: Pharmacokinetics, metabolism, dose dependancy and gender effect after single or repeated administration to human healthy volunteers, ARZNEI-FOR, 49(8), 1999, pp. 699-704
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 - Part II: Pharmacokinetics in primates after repeated oral or single intravenous administration
Authors: Duchene, P Guidicelli, MD Tran, G Ladure, P Ollivier, R Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 - Part II: Pharmacokinetics in primates after repeated oral or single intravenous administration, ARZNEI-FOR, 49(7), 1999, pp. 608-611
Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 part 1: Pharmacokinetics and tissular distribution in Sprague-Dawley rats
Authors: Duchene, P Tran, G Ladure, P Ollivier, R Buzas, A Merour, JY Houin, G
Citation: P. Duchene et al., Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113 part 1: Pharmacokinetics and tissular distribution in Sprague-Dawley rats, ARZNEI-FOR, 49(6), 1999, pp. 504-508
Risultati: 1-3 |